Vidwan-ID : 61087



  • Dr Vishal Kumar Gupta

  • Professor
  • JSS Medical College
Publications 2007 - 2023

Publications

  • 81
    Journal Articles
  • 4
    Book Chapter
  • 32
    Review
  • 1
    Projects
  • 23
  • 2
  • 26

Citations / H-Index

1612 Citations
18 h-index
863 Citations

Altmetrics

8
8
61
658
6

Google Scholar

Co-author Network


Expertise

Pharmacology and Pharmacy

Pharmacology and Pharmacy

Personal Information

Dr Vishal Kumar Gupta

Male
JSS College of Pharmacy Department of Pharmacology, JSS Medical College
Mysore, Karnataka, India - 570015


Experience

  • Professor

    Department of Pharmacology

    JSS Medical College


Qualification

  • Ph.D

    Rajiv Gandhi University of Health Sciences


Doctoral Theses Guided

2019

Environmental sensitive drug delivery system by using QbD approach for the treatment of diabetes mellitus

Krishnaveni D, Jagadgura Sri Shivarathreeswara University

2018

Formulation and evaluation of transdermal drug delivery system for the treatment of Alzheimer’s disease

Gundawar Ravi, JSS Academy of Higher Education & Research

2019

Environmental sensitive drug delivery system by using QbD approach for the treatment of diabetes mellitus

Krishnaveni D, Jagadgura Sri Shivarathreeswara University

2018

Formulation and evaluation of transdermal drug delivery system for the treatment of Alzheimer’s disease

Gundawar Ravi, JSS Academy of Higher Education & Research

Read Less

Membership In Professional Bodies

2008

Indian Pharmaceutical Association

Life Member

2007

Association of Pharmaceutical Teachers of India (APTI)

Life Member

2008

Indian Pharmaceutical Association

Life Member

2007

Association of Pharmaceutical Teachers of India (APTI)

Life Member

Read Less

Research Projects

Novel strategies for improving the anticancer efficacy of therapeutic nucleic acids against breast cancer stem cells: implication of targeted/combinatorial drug regimens

Funding Agency : DST-SERB

Novel strategies for improving the anticancer efficacy of therapeutic nucleic acids against breast cancer stem cells: implication of targeted/combinatorial drug regimens

Funding Agency : DST-SERB

Read Less